Netherlands Discussion Group

The Netherlands Area Biotech (NLab) Discussion Group is the first CASSS discussion group located outside the US, and is intended to enable the local area community of industry, academic and regulatory professionals to meet and share ideas and experiences, thereby working together to resolve scientific challenges in the field of biopharmaceutical development and regulation.

The NLab discussion group goals include:

  • Share learning across industry, academia and health authorities in Europe in general, and in the Netherlands in particular.
  • Generate new scientific and technical insights and solutions for developing biopharmaceutical products in the future.
  • Contribute to the expansion of CASSS’s mission, vision, influence, and community in Europe.

 

What Is Analytically Required to Submit a BLA Filling for an ADC, and How Analytics Changes and Develops during Product Development | February 2023

Coming February 2023, join Eef Dirksen of Byondis. Additional speakers, exact date and location to be announced soon!

Featured Speaker:

Image of male with text 'NLab Featured Speaker Eef Dirksen Byondis'

Eef Dirksen, Byondis

Dirksen is an analytical biochemist with expertise in the field of extended biopharmaceutical protein (e.g. monoclonal antibodies, antibody-drug conjugates) characterization. A biomolecular mass spectrometrist by training with vast experience in the top-down, middle-down and bottom-up (including proteomic) characterization of proteins. He is highly interested in using mass spectrometry-based approaches to complement ‘classical’ biophysical (i.e. spectroscopic) techniques in the (CMC) characterization of protein higher order structure.

Dirksen is currently the Group Lead NBE Extended Characterization at Byondis, leading a group of scientists within analytical development responsible for extended (biochemical and biophysical) characterization of Byondis' new biological entities (NBEs, mainly antibody-drug conjugates). Eef is an analytical biochemist with expertise in the field of extended biopharmaceutical protein (e.g. monoclonal antibodies, antibody-drug conjugates) characterization. A biomolecular mass spectrometrist by training with vast experience in the top-down, middle-down and bottom-up (including proteomic) characterization of proteins. He is highly interested in using mass spectrometry-based approaches to complement ‘classical’ biophysical (i.e. spectroscopic) techniques in the (CMC) characterization of protein higher order structure.  

 

Attend

Lab Automation | 6 October 2022 17:00-19:00 CET

Location:
Leiden University Medical Center
Leiden, Netherlands

This interactive discussion group includes a presentation on Lab Automation, open Q&A, and networking for all attendees. Snacks and beverages will be provided. There is no cost to register. Registration closed 5 October 2022.

Program
16:30 - 17:00

Registration and Networking
 

17:00 - 18:15

Introductions and Presentation
 

18:15 - 19:00

Networking


Specific location information including directions and transportation/parking information will be provided to registered attendees prior to the meeting. You must register in advance in order to attend.

Thank You for Joining Us

We appreciate your participation in the Netherlands Area Biotech (NLab) Discussion Group and hope you consider joining us at the next meeting. More information coming soon.

Image with text 'casss discussion groups'